Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |